Ruifa Han

1.5k total citations
72 papers, 1.1k citations indexed

About

Ruifa Han is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Ruifa Han has authored 72 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 20 papers in Surgery and 13 papers in Cancer Research. Recurrent topics in Ruifa Han's work include Bladder and Urothelial Cancer Treatments (15 papers), Epigenetics and DNA Methylation (8 papers) and Immune cells in cancer (7 papers). Ruifa Han is often cited by papers focused on Bladder and Urothelial Cancer Treatments (15 papers), Epigenetics and DNA Methylation (8 papers) and Immune cells in cancer (7 papers). Ruifa Han collaborates with scholars based in China, United States and Finland. Ruifa Han's co-authors include Weiyang Tao, Hongchi Jiang, Qi-Yin Chen, Shaobin Ni, Chunyang Wang, Hailong Hu, Yan Sun, Lianxin Liu, Yuanjie Niu and Liwei Liu and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ruifa Han

68 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruifa Han China 19 469 350 221 171 171 72 1.1k
Merja Bläuer Finland 23 489 1.0× 334 1.0× 238 1.1× 252 1.5× 252 1.5× 61 1.6k
Maria Kolatsi‐Joannou United Kingdom 20 731 1.6× 359 1.0× 178 0.8× 159 0.9× 41 0.2× 28 1.4k
Zuocheng Yang China 15 748 1.6× 211 0.6× 131 0.6× 59 0.3× 100 0.6× 55 1.2k
Ninghong Song China 18 632 1.3× 176 0.5× 334 1.5× 226 1.3× 437 2.6× 102 1.5k
Tsuyoshi Oikawa Japan 12 648 1.4× 223 0.6× 303 1.4× 66 0.4× 85 0.5× 29 1.2k
Justyna Szumiło Poland 18 255 0.5× 227 0.6× 224 1.0× 278 1.6× 111 0.6× 129 1.1k
Joon Ho Lee South Korea 19 371 0.8× 129 0.4× 122 0.6× 161 0.9× 149 0.9× 45 999
Zubaida Saifudeen United States 23 882 1.9× 93 0.3× 219 1.0× 126 0.7× 73 0.4× 49 1.2k
Steffan D. Bos Netherlands 21 526 1.1× 252 0.7× 219 1.0× 170 1.0× 305 1.8× 44 1.5k
Raffaele Rossiello Italy 20 662 1.4× 283 0.8× 153 0.7× 206 1.2× 189 1.1× 52 1.4k

Countries citing papers authored by Ruifa Han

Since Specialization
Citations

This map shows the geographic impact of Ruifa Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruifa Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruifa Han more than expected).

Fields of papers citing papers by Ruifa Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruifa Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruifa Han. The network helps show where Ruifa Han may publish in the future.

Co-authorship network of co-authors of Ruifa Han

This figure shows the co-authorship network connecting the top 25 collaborators of Ruifa Han. A scholar is included among the top collaborators of Ruifa Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruifa Han. Ruifa Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jiang, Xiaoqing Yang, Wenjie Tian, et al.. (2021). Progress in studies on pathological changes and future treatment strategies of obesity-associated female stress urinary incontinence: a narrative review. Translational Andrology and Urology. 10(1). 494–503. 7 indexed citations
2.
Kitsera, Nataliya, et al.. (2020). The Importance of Socio-Psychological Factors and Lifestyle in ShapingHealth and Life Expectancy among Longlivers from PrecarpathianRegion (West Ukraine). 9(7). 41–47.
3.
Han, Ruifa, et al.. (2019). MicroRNA-34a suppresses aggressiveness of hepatocellular carcinoma by modulating E2F1, E2F3, and Caspase-3. SHILAP Revista de lepidopterología. 6 indexed citations
4.
Han, Ruifa, et al.. (2019). Analysis Of Re-Hospitalizations For Patients With Heart Failure Caused By Coronary Heart Disease: Data Of First Event And Recurrent Event. SHILAP Revista de lepidopterología.
5.
Ren, Na, et al.. (2017). Vasohibin-1 inhibits angiogenesis and suppresses tumor growth in renal cell carcinoma. Oncology Reports. 38(2). 1021–1028. 9 indexed citations
6.
Xu, Yong, Hailong Hu, Changwen Zhang, et al.. (2016). Polymorphism in <em>IGFBP3</em> gene is associated with prostate cancer risk: an updated meta-analysis. OncoTargets and Therapy. Volume 9. 4163–4171. 5 indexed citations
7.
Shang, Zhiqun, Yanjun Li, Minghao Zhang, et al.. (2015). Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression. Molecular Cancer Therapeutics. 14(11). 2586–2594. 36 indexed citations
8.
Sun, E, Lining Wang, Xiaodong Zhou, et al.. (2015). Recombinant h IFN-α2b-BCG inhibits tumor growth in a mouse model of bladder cancer. Oncology Reports. 34(1). 183–194. 5 indexed citations
9.
Zhang, Wei, et al.. (2014). Meta-analysis of studies on the association between the NF-κB1-94ins/del ATTG promoter polymorphism and cancer. Tumor Biology. 35(12). 11921–11931. 6 indexed citations
10.
Ren, Na, et al.. (2013). Pure malignant rhabdoid tumor of the left kidney in an adult: A case report and review of the literature. Oncology Letters. 5(5). 1481–1484. 7 indexed citations
11.
Du, E, Hong Li, Shunying Jin, et al.. (2013). Evidence that TMEM67 causes polycystic kidney disease through activation of JNK/ERK‐dependent pathways. Cell Biology International. 37(7). 694–702. 4 indexed citations
12.
Yu, Lei, et al.. (2010). Prognostic significance of Aurora-A expression in human bladder cancer. Acta Histochemica. 113(5). 514–518. 25 indexed citations
13.
Wang, Chunyang, Weiyang Tao, Youdong Wang, et al.. (2010). Rosuvastatin, Identified From a Zebrafish Chemical Genetic Screen for Antiangiogenic Compounds, Suppresses the Growth of Prostate Cancer. European Urology. 58(3). 418–426. 98 indexed citations
14.
Cheng, Bo, et al.. (2009). Expression and significance of endostatin,VEGF and MVD in renal cell carcinoma. Shandong yiyao. 49(22). 10–12. 1 indexed citations
15.
Wang, Chunyang, et al.. (2009). SRD5A2 V89L polymorphism and prostate cancer risk: A meta‐analysis. The Prostate. 70(2). 170–178. 18 indexed citations
16.
Liu, Liwei, et al.. (2009). Association Between Manganese Superoxide Dismutase Gene Polymorphism and Risk of Prostate Cancer: A Meta-analysis. Urology. 74(4). 884–888. 25 indexed citations
17.
Niu, Yuanjie, Shuyuan Yeh, Hiroshi Miyamoto, et al.. (2008). Tissue Prostate-Specific Antigen Facilitates Refractory Prostate Tumor Progression via Enhancing ARA70-Regulated Androgen Receptor Transactivation. Cancer Research. 68(17). 7110–7119. 68 indexed citations
18.
Han, Ruifa. (2008). The Study on the Method of Predicting Renal Function Recoverability of Obstructed Renal Failure with Resistive Index by Two-dimensional Ultrasound.
19.
Liu, Zijing, Hong Li, Xuemei Hu, et al.. (2008). Control of Precerebellar Neuron Development byOlig3bHLH Transcription Factor. Journal of Neuroscience. 28(40). 10124–10133. 39 indexed citations
20.
Wang, Yuliang, Yawu Liu, Ruifa Han, et al.. (2007). Hemostatic variation during perioperative period of orthotopic liver transplantation without venovenous bypass. Thrombosis Research. 122(2). 161–166. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026